openPR Logo
Press release

Hear from Amgen speaking at SMi’s 4th annual Conference and Exhibition: Pre-filled Syringes West Coast 2019

04-25-2019 12:55 PM CET | Health & Medicine

Press release from: SMi Group

Hear from Amgen speaking at SMi’s 4th annual Conference

Hear from Amgen as they will be presenting the Keynote Address: Platform approach for combination products and devices on day one by Ronald Forster, Executive Director, Amgen and Kesley E. Gallagher, Director of External Engagement, Combination Products, Amgen at the 4th annual conference and exhibition taking place June 3rd - 4th in San Diego, USA.

Below is a summary of Ron Forster and Kesley Gallagher’s presentation:
Opening Keynote Address: Overcoming the challenges in development of injectable protein formulations - Day 1 | 09:10

- HFE assessment considerations
- Challenges in biocompatibility
- The balance between volume and viscosity
- The future of the platform approach for devices

Kesley Gallagher is the Director of External Engagement, Combination Products, at Amgen in Thousand Oaks, CA. She has worked in the pharmaceutical and medical device arenas for over 20 years in both Quality Assurance and Regulatory Affairs. Her prior responsibilities include Medical Device Regulation (MDR) implementation for both CE marked devices and products that will require notified body opinion. She led teams for the global submissions and approvals for the Repatha Pushtronex and managed the regulatory aspects of the Neulasta OnPro; these are Amgen’s first on-body injectors. Prior to joining Amgen, Kesley was an RA Manager at Abbott Medical Optics, specializing in new product development for eye care products and ophthalmologic surgical femtosecond lasers. Kesley has an MS in Regulatory Science from the University of Southern California and an BA in Biology/Chemistry from Bowdoin College.
----------------------------------
Ronald Forster, Executive Director, Amgen will also be moderating a panel discussion on the future regulatory trends and covering the following:

- The European Medical Device Regulation
- The emerging market in China
- Brexit and how it will affect the device industry
- Regulatory strategies for wearables, software-based medical devices and integrated devices

Dr. Forster is the Executive Director, Device Final Drug Product Technology department at Amgen Inc. Responsible for all Container Closure Systems, their integration into combination products, devices and drug substance systems. His team has developed and published numerous standards for Biological Packaging systems, lead multi-company teams to establish guidance’s in Biological Packaging development, and serves on numerous customer advisory boards for packaging suppliers.

He is also a Board of Director member as well as head of the Technical Advisory Committee for the Suzhou Industrial Park Biologics and Pharmaceutical Packaging institute (Upon accreditation this facility will become the Chinese National Biological Packaging Testing Laboratories)
Prior to joining Amgen, Ron was with Merck Inc. where he was Senior Principle Engineer leading a group that implement Quality by Design for primary packaging systems from early clinical development through commercial supply chain systems. He was a key leader in advancing the Merck Commercialization process and served as a global manufacturing lead on a key product franchise board.

Ron has an Interdisciplinary Ph.D. from Rutgers University in Chemical Engineering, Ceramic Engineering, and Mechanics and Materials Science.
For those looking to attend there is currently $100 early-bird saving, ending April 30th.

Further information is available at: www.prefilled-syringes-westcoast.com/openpr6

SMi presents the 4nd Annual Conference:
Pre-filled Syringes – West Coast 2019
Date: June 3-4, 2019
Workshops: June 5 21019
Location: Hyatt Regency Mission Bay, San Diego, California, USA
Website: www.prefilled-syringes-westcoast.com/openpr6

---ENDS---

Contact Information:
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6048 / Email: hsidhu@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

1 Westminster Bridge Road

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hear from Amgen speaking at SMi’s 4th annual Conference and Exhibition: Pre-filled Syringes West Coast 2019 here

News-ID: 1718104 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Amgen

Biotechnology Market Set for Rapid Growth| Top Players: Amgen Inc, Amgen Inc, Ce …
Global Biotechnology Market is set to exceed USD 775 billion by 2024; according to a new research report by Global Market Insights. Biopharmacy segment dominated the overall market and accounted for 61.7% revenue share in 2017. Biopharmacy segment is anticipated to grow in forthcoming years due to increasing usage of bio-recombinant proteins in several vaccines to treat numerous diseases. Biopharma companies focus on advancement of personalized medicines that should further
Biotechnology Market Competitive Landscape with Amgen Inc, Amgen Inc, Celgene, M …
The Biotechnology Market to exceed USD 775 billion by 2024 as per a new research report. Favorable government initiative and growing demand for synthetic biology will drive the biotechnology industry growth over the forecast timeframe. Also rising demand for agro-based products should fuel global biotechnology market growth. Decreasing cost of DNA sequencing from last couple of decades owing to the advances in the field of genomics will stimulate the global biotechnology
Gastrointestinal Cancer Drugs, Market: Huge Growth Opportunities by Top Manufact …
The report attempts to offer high-quality and accurate analysis of the global Gastrointestinal Cancer Drugs market, keeping in view market forecasts, competitive intelligence, and technological risks and advancements, and other important subjects. Its carefully crafted market intelligence allows market participants to understand the most significant developments in the global Gastrointestinal Cancer Drugs market that are impacting their business. Readers can become aware of crucial opportunities available in the global Gastrointestinal
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Biotechnology Market Competitive Landscape with Amgen Inc, Amgen Inc, Celgene, M …
Biotechnology Market to exceed USD 775 billion by 2024 as per a new research report. Favorable government initiative and growing demand for synthetic biology will drive the biotechnology industry growth over the forecast timeframe. Also rising demand for agro-based products should fuel global biotechnology market growth. Decreasing cost of DNA sequencing from last couple of decades owing to the advances in the field of genomics will stimulate the global biotechnology market. Furthermore,
2018 Biologic Drugs Market Future by Manufacturers- Roche, Abbott Laboratories, …
Download PDF Sample @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1656420 The Global Biologic Drugs Industry Report 2018 is a professional and in-depth study on the current state of the Biologic Drugs Market. Key Companies Analysis- Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis, Eli Lilly, Amgen Complete report on Biologic Drugs market spread across 94 pages, profiling 10 companies and supported with